EHK Clusters 2026 Report: Enhancements in Dutch...

By João L. Carapinha

June 12, 2025

The EHK clusters 2026 report from the Dutch Healthcare Institute (Zorginstituut Nederland) proposes significant updates to the classification of extremely high-cost pharmaceuticals. This initiative ensures equitable risk equalization among health ...
Telemedicine Growth Strategies: Insights from the WHO European Region
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
Quantifying EU Medicine Access Challenges
Revitalizing Innovation: The Impact of UK Medicine Payment Rates
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
NICE HealthTech Reforms: Accelerating Digital Innovation in NHS and Global He...
Allopurinol Designated an Orphan Drug for Marfan Syndrome
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
EU Patent Licensing Framework: Enhancing Crisis Management in the EU
EU Establishes Expert Panel for Orphan Paediatric Devices
High Orphan Drug Prices Persist Despite Market Exclusivity Expiration